Radical Nephroureterectomy Without Patient or Port Repositioning Using the Da Vinci Xi Robotic System: Initial Experience

Urology ◽  
2016 ◽  
Vol 92 ◽  
pp. 136-139 ◽  
Author(s):  
Omer Burak Argun ◽  
Panagiotis Mourmouris ◽  
Ilter Tufek ◽  
Mustafa Bilal Tuna ◽  
Selcuk Keskin ◽  
...  
2018 ◽  
Vol 26 (2) ◽  
pp. 192-200 ◽  
Author(s):  
Yu-Min Huang ◽  
Yan Jiun Huang ◽  
Po-Li Wei

Purpose. Robotic surgery for colorectal cancer is an emerging technique. Potential benefits as compared with the conventional laparoscopic surgery have been demonstrated. However, experience with the previous da Vinci Si robotic system revealed several unsolved problems. The novel features of the new da Vinci Xi increase operational flexibility and maneuverability and are expected to facilitate the performance of multiquadrant surgery. Methods. Between December 2011 and May 2015, 120 patients with colon or rectal cancer were operated on using the Si robotic system (the Si group). Between May 2015 and October 2017, 60 more patients with colon or rectal cancer were operated on using the Xi robotic system (the Xi group). The clinicopathological characteristics and perioperative outcomes of these 2 groups of patients were compared. Results. The 2 groups of patients were comparable with regard to baseline clinical characteristics, types of resection performed, and the proportion of patients undergoing neoadjuvant chemoradiation therapy. The statuses of resection margin, the numbers of lymph nodes harvested, and the rates of postoperative complications were also similar between the 2 groups. Nevertheless, a lower rate of diverting ileostomy, a shorter operation time, less estimated blood loss, and a faster postoperative recovery was observed in the Xi group. Conclusions. Colorectal cancer surgery using the Xi robotic system was associated with improved perioperative outcomes. These benefits may be attributed to its improved, more user-friendly design.


2019 ◽  
Vol 19 (3) ◽  
pp. 59 ◽  
Author(s):  
Hye Jeong Yoon ◽  
Jong-hyuk Ahn ◽  
Jae Hwan Kim ◽  
Jin Wook Yi ◽  
Min Hee Hur

2020 ◽  
Vol 104 (9-10) ◽  
pp. 710-715
Author(s):  
Yifan Chang ◽  
Weidong Xu ◽  
Xiaojun Lu ◽  
Yi Zhou ◽  
Ming Ji ◽  
...  

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 118-118
Author(s):  
Sabita Jiwnani ◽  
Umasankar Tantravahi ◽  
Parag Ingle ◽  
Vijayraj Patil ◽  
George Karimundackal ◽  
...  

Abstract Background Esophagectomy is a daunting procedure with a steep learning curve. Minimally invasive esophagectomy is associated with reduced perioperative complications. However, most studies so far have evaluated thoracoscopic or laparoscopic approaches. We describe our initial experience with robotic esophagectomy using the da Vinci Xi system. Methods We performed a retrospective analysis of a prospectively maintained database of patients operated with radical intent for esophageal cancer between November 2014 and November 2017. Results Thirty-four of the 483 curative esophagectomies were performed robotically. We performed the thoracic part in the semi-prone position and the abdominal part in a supine position. The thoracic component of the procedure was completed robotically in all 34 patients. For the abdominal approach, 19(55.9%) patients underwent gastric mobilization by the robotic approach, 9(26.5%) by the laparoscopic approach, and 6(17.6%) by laporotomy. The median age was 51 years and 76.5% of the patients were male. 73.5% of the patients had T3 tumours and 52.9% of the patients did not have significant nodes (N0) on preoperative imaging by PET-CT. 70.6% of the patients received neoadjuvant chemotherapy and 2.9% of the patients received neoadjuvant chemoradiotherapy. Standard two field (infracarinal and abdominal) lymphadenectomy was performed in 88.2% and three field lymphadenectomy in 11.8%. The median blood loss was 275 ml, with 85% of patients having blood loss below 400ml. The total surgical time (including docking and changing patient position) was 390 min. No patient needed intra or post-operative blood transfusion. Median ICU and hospital stay were 0.6 days and 10 days respectively. Major morbidity (Clavin-Dindo score > 3A) occurred in 17.6% with one post-operative mortality (2.9%). Pulmonary complications were seen in 8.8% and anastomotic leak in 11.8%. The median lymph nodes retrieved were 18. At a median of 24-months follow-up, the disease free survival was 58%, and the overall survival was 70%. Conclusion Transthoracic total esophagectomy is safe and feasible through the robotic approach. Larger studies with longer follow-up are needed to establish robotic esophagectomy as a standard surgical option for patients with esophageal cancer. Disclosure All authors have declared no conflicts of interest.


Sign in / Sign up

Export Citation Format

Share Document